Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that the company will present data from ...

Euthanasia protocols rely on off-label drugs. With little data and no oversight on complications, how do we know the death is truly painless?

Tyge Tind Tindholdt (born 1968) PhD, specialist in plastic surgery and senior consultant. He has contributed ideas, corrections, feedback and discussion. The author has completed the ICMJE form and ...

BACKGROUND: The disruption of the blood–brain barrier (BBB) is a central pathogenic event in many central nervous system disorders. However, the mechanisms regulating BBB function remain incompletely ...

Cancer nanotechnology is a branch of nanotechnology concerned with the application of both nanomaterials (such as nanoparticles for tumour imaging or drug delivery) and nanotechnology approaches (such ...

Figure 1: Scanning electron micrograph of a human neutrophil, which shows its extensively wrinkled surface.

Second-line treatments are used when the first treatment doesn't work, stops working, or causes bad side effects. Clinical trials can offer new treatment options that might work better than standard ...

In 2025, U.S. News & World Report named the University of Texas MD Anderson Cancer Center in Houston, Texas, the top cancer hospital in the U.S. This hospital is one of the three original ...